Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis

P-H Zahl, Karsten Juhl Jørgensen, P C Gøtzsche

    69 Citationer (Scopus)

    Abstract

    Published lead time estimates in breast cancer screening vary from 1 to 7 years and the percentages of overdiagnosis vary from 0 to 75%. The differences are usually explained as random variations. We study how much can be explained by using different definitions and methods.
    OriginalsprogEngelsk
    TidsskriftB J C
    Vol/bind109
    Udgave nummer7
    Sider (fra-til)2014-9
    Antal sider6
    ISSN0007-0920
    DOI
    StatusUdgivet - 1 okt. 2013

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis'. Sammen danner de et unikt fingeraftryk.

    Citationsformater